Compare BORR & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BORR | NEOG |
|---|---|---|
| Founded | 2016 | 1981 |
| Country | Bermuda | United States |
| Employees | N/A | 1456 |
| Industry | Oil & Gas Production | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.1B |
| IPO Year | 2017 | 1995 |
| Metric | BORR | NEOG |
|---|---|---|
| Price | $4.23 | $9.41 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 4 |
| Target Price | $6.25 | ★ $10.67 |
| AVG Volume (30 Days) | ★ 4.5M | 1.7M |
| Earning Date | 05-20-2026 | 04-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.02 |
| Revenue | N/A | ★ $894,661,000.00 |
| Revenue This Year | $5.80 | N/A |
| Revenue Next Year | $21.67 | N/A |
| P/E Ratio | ★ $20.64 | $480.50 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.86 | $4.56 |
| 52 Week High | $6.66 | $11.43 |
| Indicator | BORR | NEOG |
|---|---|---|
| Relative Strength Index (RSI) | 42.85 | 47.06 |
| Support Level | $4.10 | $8.82 |
| Resistance Level | $4.61 | $9.56 |
| Average True Range (ATR) | 0.17 | 0.33 |
| MACD | 0.02 | -0.04 |
| Stochastic Oscillator | 38.24 | 24.72 |
Borr Drilling Ltd is an offshore shallow-water drilling contractor providing services to the oil and gas industry. Its operations focus on the ownership, contracting, and operation of jack-up rigs in shallow-water areas, including the provision of related equipment and work crews to conduct oil and gas drilling and workover operations for exploration and production (E&P) customers. The company contracts its rigs on a dayrate basis to drill wells for integrated oil companies, state-owned national oil companies, and independent oil and gas companies. It operates in one reportable segment.
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.